FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns medical device introduced into lumen of any part of body in order to deliver drug for treatment of medical conditions associated with lumen of body part, as well as method for treatment applying such device at physiologic pH level. Such conditions include restenosis, atherosclerosis, and accumulation of plaques in lumen of body part. Device can include stent, cylinder, balloon catheter, stent installed on balloon, and has external surface covered with two or more nano vehicles having multiple average diameters. Multitude of nano vehicles have average diameter, acceptable for penetration through one or more layers of two or more layers of lumen of body part - intima, middle layer, and adventitial layer of vessel / vessels. Nano vehicle includes drug surrounded by encapsulating medium which contains one or more of biological agent, filler based on blood, and phospholipid, dissolved at pH less than 7.4.
EFFECT: group of inventions provides release and contact with drug only in destination tissues, with prevention of focal restenosis, stabilization of drug by encapsulating medium, with improved affinity of carriers for destination tissues, improvement of target delivery during degradation of encapsulating medium.
26 cl, 6 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION-DELIVERING MEDICAL DEVICE, METHOD OF OBTAINING THEREOF AND METHOD OF MEDICATION DELIVERY | 2010 |
|
RU2573045C2 |
STENT WITH DOUBLE DRUG RELEASE | 2010 |
|
RU2552086C2 |
IMPLANTABLE DEVICE WITH INCREASED DRUG DELIVERY AREA | 2018 |
|
RU2810457C2 |
LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR STIMULATORS | 2008 |
|
RU2510654C2 |
BARE METAL STENT WITH MEDICATION-RELEASING RESERVOIRS | 2011 |
|
RU2573107C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
LOCAL VASCULAR DELIVERY OF PROBUCOL, ALONE OR IN COMBINATION WITH SIROLIMUS, FOR TREATMENT OF RESTENOSIS, VULNERABLE PLAQUES, AAA (ABDOMINAL AORTA ANEURISM) AND STROKE | 2008 |
|
RU2481084C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF ACTIVE SUBSTANCES | 2009 |
|
RU2513153C2 |
RAPAMICIN-RELEASING STENT | 2010 |
|
RU2563429C2 |
COATING FOR AN INTRALUMINAL DIVERGENT CATHETER, PROVIDING CONTACT DELIVERY OF MICRORESERVOIRS WITH A DRUG PREPARATION | 2015 |
|
RU2721655C2 |
Authors
Dates
2016-12-27—Published
2010-05-21—Filed